×
For best experience we recommend to activate Javascript in your browser.
CD40 Ligand antibody (AA 48-244)
This anti-CD40 Ligand antibody is a Mouse Monoclonal antibody detecting CD40 Ligand in WB, IHC, IP and ICC. Suitable for Human.
Quick Overview for CD40 Ligand antibody (AA 48-244) (ABIN7614552)
Target
See all CD40 Ligand (CD40LG) Antibodies
CD40 Ligand (CD40LG)
Reactivity
All reactivities for CD40 Ligand antibodies
Human
Host
All hosts for CD40 Ligand antibodies
Mouse
Clonality
All clonalities for CD40 Ligand antibodies
Monoclonal
Conjugate
All conjugates for CD40 Ligand antibodies
This CD40 Ligand antibody is un-conjugated
Application
All applications for CD40 Ligand antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Clone
C2
Product Details anti-CD40 Ligand Antibody
(hide)
Binding Specificity
All epitopes for CD40 Ligand antibodies
AA 48-244
Purpose
Cluster Of Differentiation 40 Ligand (CD40L) Monoclonal Antibody
Sequence
Arg48~Pro244
Characteristics
The Cluster Of Differentiation 40 Ligand (CD40L) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Isotype
IgG2b kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CD40 Ligand
(hide)
Target
CD40 Ligand (CD40LG)
Alternative Name
CD40L
Gene ID
959
UniProt
P29965
Pathways
NF-kappaB Signaling , Production of Molecular Mediator of Immune Response , Cancer Immune Checkpoints
Recently viewed
(hide)
Chat with us , powered by LiveChat